Novo Nordisk and Eli Lilly $LLY Lead Obesity Market with...
Key Takeaways The global market for obesity and diabetes treatments is projected to surpass USD 100 billion by 2030, propelled by rising prevalence and pharmacological innovation. Novo Nordisk and Eli...